Cargando…
Cancer immunotherapy beyond immune checkpoint inhibitors
Malignant cells have the capacity to rapidly grow exponentially and spread in part by suppressing, evading, and exploiting the host immune system. Immunotherapy is a form of oncologic treatment directed towards enhancing the host immune system against cancer. In recent years, manipulation of immune...
Autores principales: | Marin-Acevedo, Julian A., Soyano, Aixa E., Dholaria, Bhagirathbhai, Knutson, Keith L., Lou, Yanyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767051/ https://www.ncbi.nlm.nih.gov/pubmed/29329556 http://dx.doi.org/10.1186/s13045-017-0552-6 |
Ejemplares similares
-
Next generation of immune checkpoint therapy in cancer: new developments and challenges
por: Marin-Acevedo, Julian A., et al.
Publicado: (2018) -
Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies
por: Soyano, Aixa E., et al.
Publicado: (2018) -
Next generation of immune checkpoint inhibitors and beyond
por: Marin-Acevedo, Julian A., et al.
Publicado: (2021) -
Emerging therapeutic agents for lung cancer
por: Dholaria, Bhagirathbhai, et al.
Publicado: (2016) -
Survival trends among non‐small‐cell lung cancer patients over a decade: impact of initial therapy at academic centers
por: Lou, Yanyan, et al.
Publicado: (2018)